Načítá se...
MicroRNA dysregulation and multi-targeted therapy for cancer treatment
We established that loss of miR-15a/16-1 genes on chromosome 13q14 is the most common alteration in Chronic Lymphocytic Leukemia (CLL) and that miR-15/16 are crucial negative regulator of BCL-2, an antiapoptotic gene overexpressed in most CLLs and in many other malignancies. We have also shown that...
Uloženo v:
| Vydáno v: | Adv Biol Regul |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7056524/ https://ncbi.nlm.nih.gov/pubmed/31640928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbior.2019.100669 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|